SUBSCRIBE
SUBSCRIBE

Omeros Corporation

NEWS
Business
BioSpace Online Community Shares Job Openings With Industry Colleagues Who Lost Jobs
Job hunting can be a challenging time for people. Finding open positions that fit your skill set and then competing with other highly-qualified people can be bruising, especially if you’re already a bit damaged from a recent layoff.
September 7, 2018
 · 
3 min read
 · 
Alex Keown
Amneal and Impax to Marry, Creating the 5th Larges
BioForest
Why This Overlooked Seattle Drugmaker Could be the Best Biotech Buy Right Now
Omeros is getting a lot of love from investors and analysts these days.
November 29, 2017
 · 
3 min read
 · 
Mark Terry
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Drug Development
Seattle’s Omeros Fires Back But Still Won’t Answer Basic Questions About Key Drug
August 24, 2017
 · 
3 min read
Drug Development
Omeros: Next Big Thing In Biotech
July 5, 2017
 · 
1 min read
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Policy
Omeros Pursuing Legal Action Against Short Seller for Report That Caused Stock to Tank This Week
June 29, 2017
 · 
2 min read
Job Trends
Seattle-Based Omeros Beefs Up Salesforce as Cataract Surgery Drug Sales Take Off in Q1
May 11, 2016
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Omeros Corporation Suspends Enrollment In Huntington’s Disease Trial; Stock Down 11.36% At 8:40AM ET On Tuesday
October 21, 2014
 · 
2 min read
Load More
JOBS
IN THE PRESS
Press Releases
Omeros Announces Robust Results for Narsoplimab Expanded Access Program in TA-TMA
February 20, 2025
 · 
15 min read
Press Releases
Omeros Corporation Announces Availability on its Website of Materials Accompanying Narsoplimab Presentations at the 2025 Tandem Meetings
February 17, 2025
 · 
6 min read
Press Releases
Omeros Corporation Announces Upcoming Presentations Detailing Outcomes of Narsoplimab Treatment for TA-TMA Under an Expanded Access Program
February 10, 2025
 · 
7 min read
Press Releases
Omeros Announces Update on Statistical Analysis of Narsoplimab Pivotal Trial Primary Endpoint
January 16, 2025
 · 
11 min read
Press Releases
Omeros’ Narsoplimab Meets its Pivotal Trial Primary Endpoint – Statistical Analysis Shows Survival Superiority Over External Control in Patients with TA-TMA
December 20, 2024
 · 
12 min read
Press Releases
Omeros Corporation Announces Presentation of Positive Zaltenibart Data at ASH Annual Meeting
December 10, 2024
 · 
4 min read
Press Releases
Omeros Corporation Announces Upcoming Presentations at ASH Annual Meeting
December 2, 2024
 · 
3 min read
Press Releases
Omeros Corporation Provides Update on Progress Toward BLA Resubmission
November 21, 2024
 · 
5 min read
Press Releases
Omeros Corporation Reports Third Quarter 2024 Financial Results
November 14, 2024
 · 
19 min read
Press Releases
Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2024
November 12, 2024
 · 
2 min read
Load More